NCT05909280

Brief Summary

Invasive pressure-volume (PV) loop measurements have the potential to confirm or refute earlier computer simulations and animal studies regarding changes in cardiovascular physiology induced by (veno-arterial) ECMO. PV loop analysis could create a framework for the (ICU-) clinician for VA-ECMO weaning guidance, based on a patient's individual hemodynamic profile. PV loop measurements may, in future, serve as a guide for which patient would benefit most from (prolonged) VA-ECMO support or which patient would require additional LV unloading. Within the context of PLUTO-I, patients on VA-ECMO support who are eligible for weaning from VA-ECMO will undergo biventricular PV loop measurements on different intensities of extracorporeal support.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 14, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 13, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2024

Completed
Last Updated

January 5, 2024

Status Verified

January 1, 2024

Enrollment Period

2 years

First QC Date

February 13, 2023

Last Update Submit

January 3, 2024

Conditions

Keywords

Pressure-volume loopCardiac mechanoenergetics

Outcome Measures

Primary Outcomes (3)

  • Stroke Work in mmHg/mL

    The energy necessary for the myocardium to propel blood in the ventricle. Expressed by PV-loop reconstructions based on conductance catheter measurements.

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

  • Potential Energy in mmHg/mL

    The (unused) energy stored in the myocardium following systole. Expressed by PV-loop reconstructions based on conductance catheter measurements.

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

  • Pressure-Volume Area in mmHg/mL

    The net metabolic demand of the myocardium throughout the cardiac cycle. Expressed by PV-loop reconstructions based on conductance catheter measurements.

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

Secondary Outcomes (13)

  • Stroke Volume in mL

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

  • Cardiac Output

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

  • Preload recruitable stroke work in mmHg/mL

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

  • Tau in ms

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

  • Systolic and diastolic intraventricular dyssynchrony in %

    Perprocedural (i.e. when ECMO flow is decreased from maximal to minimal L/min)

  • +8 more secondary outcomes

Study Arms (1)

Observational arm

Patients on VA-ECMO, eligible for weaning

Other: Pressure-volume loop measurements

Interventions

Pressure-volume loop measurements using a conductance catheter

Observational arm

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients on VA-ECMO support for any indication

You may qualify if:

  • \- On VA-ECMO support for any indication

You may not qualify if:

  • Age \< 18 years
  • Re-initiation of VA-ECMO during the same ICU admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus Medical Center

Rotterdam, South Holland, 3015GD, Netherlands

RECRUITING

Study Officials

  • Nicolas M Van Mieghem, Prof MD PhD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Antoon JM van den Enden, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Interventional Cardiology, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

February 13, 2023

First Posted

June 18, 2023

Study Start

November 14, 2022

Primary Completion

November 14, 2024

Study Completion

December 14, 2024

Last Updated

January 5, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations